Brachytherapy may continue following uterine perforation in cervical cancer patients

Covid-19: Moderna and Novavax vaccines to be tested in mixing vaccines trial
14 April 2021
Clot questions over AstraZeneca and J&J vaccine
14 April 2021

Brachytherapy may continue following uterine perforation in cervical cancer patients

A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells, may continue safely, potentially without delay or antibiotics, in cervical cancer patients following uterine perforation.

Comments are closed.